Paula Fentiman
The makers of indigestion medicine Gaviscon yesterday denied attempting to maintain a market monopoly, thereby "cheating the NHS" out of millions of pounds, after a series of e-mails were leaked.
Executives at Reckitt Benckiser created obstacles to rival products, the e-mails suggested.
A former employee told BBC Newsnight that Reckitt Benckiser had "cheated the NHS" and could have saved it "millions of pounds".
But the drug firm said yesterday it was a "responsible company" and denied it had enough power to carry out such a scheme.
It has, however, launched an internal investigation into the "inappropriate sentiment" featured in the memos.
The claims centre around what happened after the remedy came off patent nine years ago. It should have paved the way for cheap generic copies to be made, but the documents include details of how the company said it could slow down the process.
Executives at the Hull-based manufacturer boasted that they had influenced regulatory bodies to delay the introduction of a generic product by objecting on a number of grounds including health and safety.
One wrote: "Should we not drag it out as long as possible - £9m of business is at stake."
In other e-mails, executives wrote of their intention to create "a further barrier to competitors" and "restrict entry for new competitors".
In a statement yesterday, Reckitt Benckiser said: "We are shocked by the allegations made in the press today, and by the inappropriate sentiment expressed in some of the internal correspondence of 2003.
"Reckitt Benckiser is a responsible company in the way it conducts its business, and we have therefore instigated an immediate internal investigation, and will take action. However, we do not accept much of what has been alleged, which implies a power or patient access we simply do not possess."
The statement said Gaviscon is a "very small part" of the £350m the NHS spends on drugs to treat illnesses such as heartburn and dyspepsia.
The statement added: "The company has never objected to a monograph driven generic name being published. The timetable of which is not, and never has been, within our control - a monograph/generic name could have been published at any time by the regulators without reference to any third party."
The British Pharmacopoeia Commission said the creation of the particular stomach medicine formulations involved was complex and that the time taken was not down to any interventions or detail in the memos.
The commission "did not allow Reckitt Benckiser to influence its work to elaborate a monograph for alginate raft forming suspensions", it said.
A Department of Health spokesman said: "We would be concerned if any manufacturer of branded medicines sought to protect their patent-expired products in the manner alleged.
"We are not aware that Reckitt Benckiser have done so in this case."
Why are you making commenting on The Herald only available to subscribers?
It should have been a safe space for informed debate, somewhere for readers to discuss issues around the biggest stories of the day, but all too often the below the line comments on most websites have become bogged down by off-topic discussions and abuse.
heraldscotland.com is tackling this problem by allowing only subscribers to comment.
We are doing this to improve the experience for our loyal readers and we believe it will reduce the ability of trolls and troublemakers, who occasionally find their way onto our site, to abuse our journalists and readers. We also hope it will help the comments section fulfil its promise as a part of Scotland's conversation with itself.
We are lucky at The Herald. We are read by an informed, educated readership who can add their knowledge and insights to our stories.
That is invaluable.
We are making the subscriber-only change to support our valued readers, who tell us they don't want the site cluttered up with irrelevant comments, untruths and abuse.
In the past, the journalist’s job was to collect and distribute information to the audience. Technology means that readers can shape a discussion. We look forward to hearing from you on heraldscotland.com
Comments & Moderation
Readers’ comments: You are personally liable for the content of any comments you upload to this website, so please act responsibly. We do not pre-moderate or monitor readers’ comments appearing on our websites, but we do post-moderate in response to complaints we receive or otherwise when a potential problem comes to our attention. You can make a complaint by using the ‘report this post’ link . We may then apply our discretion under the user terms to amend or delete comments.
Post moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours.
Read the rules hereComments are closed on this article